Canadian Avonex PEN Productivity Study
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Biogen
Related studies linked through entity extraction aliases.
Observational Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JC Virus Antibody Negative Participants
- Status
- COMPLETED
- Phase
- N/A
Open-Label Study to Assess the Effect of Long-Term Prolonged-Release Fampridine (BIIB041) on Quality of Life as Reported by Participants With Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE4
An Observational Study to Collect Information on Safety and to Document the Drug Utilization of Fampyra (BIIB041) When Used In Routine Medical Practice
- Status
- COMPLETED
- Phase
- N/A
An Open-Label Immunogenicity and Pharmacokinetics Study of Daclizumab High Yield Process Prefilled Syringe in Relapsing Remitting Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE3
A Single-Dose, Open-Label, Randomized, Food Effect and Blinded, Randomized, Dose Proportionality Study in Healthy Volunteers With Bardoxolone Methyl
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Study to Evaluate the PK, Safety, and Tolerability of BG00012 in Chinese, Japanese, and Caucasian Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Natalizumab (BG00002, Tysabri) Study in Japanese Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Dexpramipexole Japanese PK Study
- Status
- COMPLETED
- Phase
- PHASE1
Study in Healthy Volunteers to Establish the BioEquivalence of Two Formulations of BG00012
- Status
- COMPLETED
- Phase
- PHASE1
A Multiple-Dose, Open-Label, Phase 1, Pharmacokinetic, Pharmacodynamic, and Safety Study of Avonex® in Chinese Healthy Volunteer Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Participants With Secondary Progressive Multiple Sclerosis
- Status
- TERMINATED
- Phase
- PHASE3
Extension Study to Evaluate Safety and Efficacy of Natalizumab in Japanese Participants With Relapsing-Remitting Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1 Study to Evaluate the PK, Safety, Tolerability of BIIB023 in Chinese, Japanese, and Caucasian Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Persistence, Adherence, Quality of Life, and Treatment Satisfaction With Avonex® PEN™.
- Status
- COMPLETED
- Phase
- N/A
Study of the Safety, Tolerability, Pharmacokinetics and Safety of BG00010 (Neublastin) in Subjects With Sciatica.
- Status
- COMPLETED
- Phase
- PHASE1
Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS)
- Status
- COMPLETED
- Phase
- PHASE2
Single Ascending Dose Study of BIIB037 in Participants With Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE1
STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- Status
- COMPLETED
- Phase
- PHASE2
Avonex PEN Satisfaction and Patients Experience Clinical Trial
- Status
- COMPLETED
- Phase
- N/A